Chengdu Bright Eye Hospital Co. Ltd. Working Capital to Net Assets Ratio
Chengdu Bright Eye Hospital Co. Ltd. working capital to net assets ratio. Chengdu Bright Eye Hospital Co. Ltd. (301239) has a Working Capital to Net Assets ratio of -0.3% as of June 2026. Working capital of CN¥-6.96 Million (current assets of CN¥1.01 Billion minus current liabilities of CN¥1.01 Billion) is measured against net assets of CN¥2.17 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Chengdu Bright Eye Hospital Co. Ltd. to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Chengdu Bright Eye Hospital Co. Ltd. (2019–2025)
Working capital to net assets ratio of Chengdu Bright Eye Hospital Co. Ltd. from 2019 to 2025. This chart shows how Chengdu Bright Eye Hospital Co. Ltd.'s Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the ratio stands at -0.3%, reflecting working capital of CN¥-6.96 Million against net assets of CN¥2.17 Billion CNY. See defensive interval ratio of Chengdu Bright Eye Hospital Co. Ltd. to measure how many days the company can operate on defensive assets alone.
Chengdu Bright Eye Hospital Co. Ltd. Working Capital to Net Assets Ratio by Year (2019–2025)
Chengdu Bright Eye Hospital Co. Ltd. working capital to net assets ratio by year from 2019 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Chengdu Bright Eye Hospital Co. Ltd. from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 301239 asset base.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -0.4% | CN¥-8.25 Million | CN¥2.07 Billion | CN¥857.88 Million | CN¥866.13 Million | ▲ +1.0 pp |
| 2024 | -1.4% | CN¥-29.83 Million | CN¥2.12 Billion | CN¥869.26 Million | CN¥899.09 Million | ▼ -8.8 pp |
| 2023 | 7.4% | CN¥171.67 Million | CN¥2.32 Billion | CN¥1.21 Billion | CN¥1.04 Billion | ▼ -21.9 pp |
| 2022 | 29.3% | CN¥605.37 Million | CN¥2.07 Billion | CN¥1.19 Billion | CN¥582.33 Million | ▲ +36.7 pp |
| 2021 | -7.4% | CN¥-70.13 Million | CN¥948.30 Million | CN¥419.50 Million | CN¥489.63 Million | ▼ -23.8 pp |
| 2020 | 16.4% | CN¥139.59 Million | CN¥853.25 Million | CN¥504.56 Million | CN¥364.97 Million | ▼ -8.6 pp |
| 2019 | 25.0% | CN¥185.81 Million | CN¥744.32 Million | CN¥397.31 Million | CN¥211.50 Million | — |